2Morkve O, Laerun OD. Flow cytometric measurement of P53 protein expression and DNA Content in paraffin enbedded tissue from bronchial carcinomas[J ]. Cytometry, 1991,12(5) :438 444
3Rothe M, Falanga V. Growth factors. Their biology and promise in dermatologic diseases aind tissue repair [ J ]. Arch Dermatol, 1989, 125(10): 1390 - 1398
4Fisher DA,Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in mammals[J]. Endocr Rev, 1990,11(3) :418-442
3Schwartz RA. Keratoacanthoma[J]. J Am Acad Dermatol, 1994,30 (1):1 -19.
4Grossnikiaus HE, Wojno TH, Yanoff M, et al. Invasive keratoacanthoma of the eyelid and ocular adnexa [ J ]. Ophthalmology, 1996,103 (6) :937.
5Slater M, Barden JA. Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotie and cell adhesion markers[J]. Histopathology,2005,47(2) :170 - 178.
6Patel A, Halliday GM, Cooke BE, et al. Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma[J]. Br J Dematol, 1994,131 (6) :789 - 798.
